Jochen Utikal
Utikal, Jochen 1974-
VIAF ID: 268302420 (Personal)
Permalink: http://viaf.org/viaf/268302420
Preferred Forms
-
100 0 _
‡a
Jochen Utikal
-
100 1 _
‡a
Utikal, Jochen
‡d
1974-
-
100 1 _
‡a
Utikal, Jochen
‡d
1974-
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| [Caterpillar dermatitis. An increasing dermatologic problem in warmer regions of Germany]. |
|
| CD30-positive lymphoproliferative disorder in a red tattoo: regional lymphomatoid papulosis type C or pseudolymphoma? |
|
| Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. |
|
| Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. |
|
| Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. |
|
| Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells. |
|
| Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage Formation. |
|
| Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma. |
|
| Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells. |
|
| Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium. |
|
| Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter. |
|
| Endothelial Notch1 Activity Facilitates Metastasis. |
|
| Function and significance of MicroRNAs in benign and malignant human stem cells. |
|
| Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and Derivatives as Potent Oct3/4 Inducers. |
|
| Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses. |
|
| Immortalization eliminates a roadblock during cellular reprogramming into iPS cells |
|
| Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. |
|
| Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. |
|
| MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma. |
|
| MicroRNAs as novel targets and tools in cancer therapy. |
|
| Multiple highly and moderately differentiated squamous cell carcinomas of the skin during vismodegib treatment of inoperable basal cell carcinoma. |
|
| Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. |
|
| NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model. |
|
| Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway |
|
| Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer. |
|
| The oak processionary moth: a new health hazard? |
|
| Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma. |
|
| Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma. |
|
| [Persistent facial erythema and edema]. |
|
| PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors. |
|
| Predictive immune markers in advanced melanoma patients treated with ipilimumab. |
|
| [Red and purple maculas and plaques at the lateral aspects of the thighs]. |
|
| Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. |
|
| Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study. |
|
| Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. |
|
| Topography of cancer-associated immune cells in human solid tumors |
|
| Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany. |
|
